Venous Thromboembolism
📧 Sign up to get email alerts when something new happens for Venous Thromboembolism.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-05-03Clinical Trial Update: Rivaroxaban in the Treatment of Venous Thromboembolism (VTE) in Cancer Patients [Phase 3]
Phase 3 trial evaluating rivaroxaban for venous thromboembolism in cancer patients has been terminated.
-
CLINICAL_TRIALS trial_result · 2021-01-13Clinical Trial Update: Delayed Versus Early Enoxaparin Prophylaxis After Traumatic Brain Injury (TBI) [Phase 1]
Phase 1 clinical trial comparing delayed versus early enoxaparin prophylaxis after traumatic brain injury completed with posted results.
-
FDA approval · 2020-12-29FDA Approved: HEPARIN SODIUM — Original Application (BE Pharmaceuticals Inc.)
FDA approved the original ANDA for Heparin Sodium from BE Pharmaceuticals Inc., providing a generic version of heparin for anticoagulation.
-
FDA approval · 2020-12-29FDA Approved: HEPARIN SODIUM — Original Application (BE Pharmaceuticals Inc.)
The FDA approved BE Pharmaceuticals Inc.'s original application for Heparin Sodium (a generic anticoagulant). It is used to prevent and trea…
-
CLINICAL_TRIALS trial_result · 2020-12-02Clinical Trial Update: Impact of Early Debriefing and Enhanced Educative Components on Direct Oral Anticoagulant Adherence After Venous Thromboembolism. [Phase 3]
Phase 3 trial evaluating whether early debriefing and enhanced educational components improve adherence to direct oral anticoagulants after …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-11-24Clinical Trial Update: Study to Assess the Safety and Efficacy of SelK2 to Prevent Blood Clots in Patients Undergoing Total Knee Replacement [Phase 2]
Phase 2 trial assessing SelK2 for safety and efficacy in preventing blood clots in patients undergoing total knee replacement has completed …
-
CLINICAL_TRIALS trial_result · 2020-10-19Clinical Trial Update: Statin Use in Patients With Acute VTE [EARLY_Phase 1]
Early-phase trial update evaluating statin use in patients with venous thromboembolism has been terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2020-09-16Clinical Trial Update: Minimization of Bleeding Related Adverse Drug Events in Plastic & Reconstructive Surgery [Phase 2]
A Phase 2 clinical trial update focusing on reducing bleeding-related adverse events in patients undergoing plastic and reconstructive surge…
-
FDA approval · 2020-07-15FDA Approved: HEPARIN SODIUM — Original Application (Meitheal Pharmaceuticals Inc.)
FDA approved Meitheal Pharmaceuticals' generic heparin sodium (Original Application) as an injectable anticoagulant. It covers the same indi…
-
CLINICAL_TRIALS trial_result · 2020-07-08Clinical Trial Update: Fixed Versus Weight-Based Enoxaparin Dosing in Thoracic Surgery Patients [Phase 2]
Phase 2 trial comparing fixed versus weight-based enoxaparin dosing in thoracic surgery patients has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-07-07Clinical Trial Update: Open Label Study Comparing Efficacy and Safety of Dabigatran Etexilate to Standard of Care in Paediatric Patients With Venous Thromboembolism (VTE) [Phase 3]
Open-label Phase 3 trial comparing dabigatran etexilate to standard of care in paediatric venous thromboembolism completed with posted resul…
-
FDA approval · 2020-06-18FDA Approved: ENOXAPARIN SODIUM — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for ENOXAPARIN SODIUM by Sandoz Inc, signaling an approved change to the product's status under the …
-
CLINICAL_TRIALS trial_result · 2020-06-04Clinical Trial Update: Safety of Dabigatran Etexilate in Blood Clot Prevention in Children [Phase 3]
Phase 3 trial assessing safety of dabigatran etexilate for venous thromboembolism prevention in children has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-04-29Clinical Trial Update: RE-COVERY DVT/PE: Global Study on Treatment Secondary Prevention of Acute Venous Thromboembolism
A completed clinical trial update on secondary prevention of acute venous thromboembolism; results posted in 2020.
-
FDA approval · 2020-04-21FDA Approved: SAVAYSA — Supplemental Application (Daiichi Sankyo Inc.)
FDA approved a supplemental application for SAVAYSA (edoxaban tosylate) submitted by Daiichi Sankyo Inc., likely updating labeling and/or in…
-
FDA approval · 2020-04-02FDA Approved: HEPARIN SODIUM — Original Application (Meitheal Pharmaceuticals Inc.)
FDA approved Meitheal Pharmaceuticals' original application for a generic heparin sodium product.
-
CLINICAL_TRIALS trial_result · 2020-04-01Clinical Trial Update: EINSTEIN Junior: Oral Rivaroxaban in Children With Venous Thrombosis [Phase 3]
Phase 3 trial update for EINSTEIN Junior assessing oral rivaroxaban in children with venous thromboembolism has completed with results poste…
-
CLINICAL_TRIALS trial_result · 2020-03-31Clinical Trial Update: Oral Apixaban (Eliquis) Versus Enoxaparin (Lovenox) for Thromboprophylaxis in Women With Suspected Pelvic Malignancy [Phase 2]
Phase 2 trial comparing oral apixaban to enoxaparin for thromboprophylaxis in women with suspected pelvic malignancy; results completed with…
-
CLINICAL_TRIALS trial_result · 2020-02-28Clinical Trial Update: PREvention of VENous ThromboEmbolism Following Radical Prostatectomy [Phase 4]
A Phase 4 clinical trial investigating prevention of venous thromboembolism after radical prostatectomy was terminated; results were posted …
-
CLINICAL_TRIALS trial_result · 2020-02-27Clinical Trial Update: StAtins for Venous Event Reduction in Patients With Venous Thromboembolism Pilot Study [Phase 2]
Pilot Phase 2 trial evaluating statins for reducing venous thromboembolism events.
-
CLINICAL_TRIALS trial_result · 2020-02-05Clinical Trial Update: Intermittent Pneumatic Compression in Surgical Patients at Extremely-high Risk for Venous Thromboembolism [NA]
A completed clinical trial evaluating intermittent pneumatic compression in surgical patients at extremely high risk for venous thromboembol…
-
CLINICAL_TRIALS trial_result · 2020-01-18Clinical Trial Update: Deep Vein Thrombosis Prophylaxis Adherence: Enoxaparin vs Rivaroxaban [Phase 4]
A phase 4 trial comparing enoxaparin to rivaroxaban for preventing deep vein thrombosis is ongoing with unknown status.
-
CLINICAL_TRIALS trial_result · 2020-01-06Clinical Trial Update: Education Bundle to Decrease Patient Refusal of VTE Prophylaxis [NA]
A completed clinical trial evaluating an education bundle to reduce patient refusal of venous thromboembolism prophylaxis.
-
CLINICAL_TRIALS trial_result · 2020-01-02Clinical Trial Update: Sickle Cell Trait and the Risk of Venous Thromboembolism
Termination of a clinical trial evaluating sickle cell trait and risk of venous thromboembolism; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2019-12-24Clinical Trial Update: Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism [Phase 3]
Phase 3 trial comparing apixaban to dalteparin for reducing blood clots in cancer-associated venous thromboembolism has completed with resul…